GeneOne Life Science Inc (011000) — Strategic Asset Allocation Index
GeneOne Life Science Inc (011000) has a Strategic Asset Allocation Index of 92.0% as of June 2023. Strategic assets (PP&E of ₩150.96 Billion plus long-term investments of ₩-) total ₩150.96 Billion, measured against net assets of ₩164.13 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check GeneOne Life Science Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
GeneOne Life Science Inc Strategic Asset Allocation Index (2009–2022)
This chart shows how GeneOne Life Science Inc's Strategic Asset Allocation Index has evolved across 14 annual periods from 2009 to 2022. As of June 2023, the index stands at 92.0%, representing strategic assets of ₩150.96 Billion against net assets of ₩164.13 Billion KRW. See GeneOne Life Science Inc (011000) flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for GeneOne Life Science Inc (2009–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for GeneOne Life Science Inc from 2009 to 2022, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see GeneOne Life Science Inc market capitalisation.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 79.6% | ₩144.37 Billion | ₩144.37 Billion | ₩- | ₩181.47 Billion | ▲ +25.8 pp |
| 2021 | 53.7% | ₩110.38 Billion | ₩110.38 Billion | ₩- | ₩205.45 Billion | ▲ +31.0 pp |
| 2020 | 22.8% | ₩22.43 Billion | ₩22.43 Billion | ₩- | ₩98.51 Billion | ▼ -20.0 pp |
| 2019 | 42.8% | ₩10.29 Billion | ₩10.00 Billion | ₩284.17 Million | ₩24.06 Billion | ▲ +20.8 pp |
| 2018 | 21.9% | ₩6.44 Billion | ₩6.11 Billion | ₩332.62 Million | ₩29.41 Billion | ▲ +11.6 pp |
| 2017 | 10.3% | ₩3.76 Billion | ₩3.43 Billion | ₩329.13 Million | ₩36.54 Billion | ▼ -3.4 pp |
| 2016 | 13.7% | ₩4.91 Billion | ₩4.29 Billion | ₩620.70 Million | ₩35.85 Billion | ▲ +4.5 pp |
| 2015 | 9.2% | ₩3.63 Billion | ₩3.05 Billion | ₩583.08 Million | ₩39.44 Billion | ▲ +2.0 pp |
| 2014 | 7.2% | ₩2.49 Billion | ₩1.70 Billion | ₩786.98 Million | ₩34.73 Billion | ▼ -2.8 pp |
| 2013 | 10.0% | ₩2.37 Billion | ₩1.43 Billion | ₩943.68 Million | ₩23.71 Billion | ▲ +3.1 pp |
| 2012 | 6.9% | ₩1.86 Billion | ₩1.86 Billion | ₩- | ₩26.74 Billion | ▼ -0.8 pp |
| 2011 | 7.7% | ₩2.61 Billion | ₩2.61 Billion | ₩- | ₩33.79 Billion | ▼ -10.1 pp |
| 2010 | 17.8% | ₩5.72 Billion | ₩5.72 Billion | ₩- | ₩32.04 Billion | ▲ +3.2 pp |
| 2009 | 14.7% | ₩5.82 Billion | ₩5.82 Billion | ₩- | ₩39.74 Billion | — |